ScholarIQanswers from OpenAlex & ORCID
Xiaobin Zheng
ResearcherPublications, citations & collaboration network
Xiaobin Zheng is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Xiaobin Zheng have?
ScholarIQindexed works
Xiaobin Zheng has 16 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Xiaobin Zheng have?
ScholarIQcitation count
Xiaobin Zheng has 393 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Xiaobin Zheng?
ScholarIQh-index
Xiaobin Zheng has an h-index of 8 in OpenAlex.
What is the i10-index of Xiaobin Zheng?
ScholarIQi10-index
Xiaobin Zheng has an i10-index of 8 in OpenAlex.
What is the ORCID of Xiaobin Zheng?
ScholarIQorcid
The ORCID for Xiaobin Zheng is on the source record.
What is the OpenAlex record for Xiaobin Zheng?
ScholarIQopenalex
The OpenAlex for Xiaobin Zheng is on the source record.
What are the most-cited papers on Xiaobin Zheng?
ScholarIQmost cited works
Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages
Shuncong Wang, Jianjun Tang, Tiantian Sun, Xiaobin Zheng, Jie Li, Hongliu Sun, Hongliu Sun, Xiuling Zhou, Cuiling Zhou, Hongyu Zhang, Zhibin Cheng, Haiqing Ma, Huanhuan Sun, Huanhuan Sun
Survival improvement in patients with non–small cell lung cancer between 1983 and 2012: Analysis of the Surveillance, Epidemiology, and End Results database
Shuncong Wang, Tiantian Sun, Huanhuan Sun, Xiaobo Li, Jie Li, Xiaobin Zheng, Saradhi Mallampati, Hongliu Sun, Xiuling Zhou, Cuiling Zhou, Hongyu Zhang, Zhibin Cheng, Haiqing Ma
Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984–2013
Haiyu Zhang, Pei X, Xiangqiong Mo, Junlan Qiu, Xiaobin Zheng, Shuncong Wang, Huanhuan Sun, Haiqing Ma
Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis
Qian Miao, Xiaobin Zheng, Longfeng Zhang, Kan Jiang, Wu B, Gen Lin
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
Xiaobin Zheng, Jing Lin, Jiani Xiong, Yanfang Guan, Bin Lan, Yi Li, Xuan Gao, Zhaodong Fei, Lisha Chen, Lizhu Chen, Ling Chen, Gang Chen, Zengqing Guo, Xin Yi, Weiguo Cao, Xinghao Ai, Chengzhi Zhou, Xiaofeng Li, Jun Zhao, Xiangtao Yan, Qitao Yu, Lu Si, Yu Chen, Chuanben Chen